LXRXLexicon Pharmaceuticals, Inc.

2.300USD-4.56%Mkt Cap: 1.02B $P/E:

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. The company develops sotagliflozin, …

Key Statistics

Company
Market Cap1.02B $
Enterprise Value838.63M $
Revenue (TTM)41.47M $
Gross Profit49.53M $
Net Income (TTM)-50.34M $
Revenue/Share0.1060 USD
Last Price2.300 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees81
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN
Valuation
P/E (Trailing)
P/E (Forward)-11.44
PEG-13.77
EV/EBITDA-15.52
EV/Revenue20.22
P/S23.39
P/B5.56
EPS (TTM)-0.14
EPS (Forward)-0.19
52W Range
1.03077% of range2.680
52W High2.680 USD
52W Low1.030 USD
Profitability
Gross Margin99.45%
Oper. Margin-3835.26%
EBITDA Margin-130.27%
Profit Margin-101.08%
ROE-46.81%
ROA-27.21%
Growth
Revenue Growth-97.60%
Earnings Growth
Cash Flow & Leverage
Operating CF-67.85M $
CapEx (TTM)
FCF Margin-107.97%
FCF Yield-4.38%
Net Debt-131.37M $
Net Debt/EBITDA2.43
Balance Sheet
Debt/Equity0.58
Current Ratio13.37
Quick Ratio13.07
Book Value/Sh0.3920 USD
Cash/Share0.4280 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Splits
Last Split1:7
Split DateMay 21, 2015
Analyst Consensus
Rating2.0 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)3.856 USD
Upside (mean)+67.7%
Target Range2.000 USD6.000 USD
$2.000+67.7% to mean$6.000
# Analysts5
Ownership
Shares Out.444.96M
Float218.99M
Insiders1.12%
Institutions83.69%
Short Interest
Short Ratio11.7d
Short % Float13.90%
Short % Out.7.38%
Shares Short32.83M
Short (prev mo.)30.78M
Technical
SMA 502.273 (+1.2%)
SMA 2001.739 (+32.2%)
Beta1.03
S&P 52W Chg18.16%
Avg Vol (30d)2.71M
Avg Vol (10d)2.84M
Technical Indicators
RSI (14)48.1
MACD0.0242
MACD Signal0.0376
MACD Hist.-0.0134
BB Upper2.488 USD
BB Middle2.356 USD
BB Lower2.224 USD
BB Width11.23%
ATR (14)0.1498 USD
Vol Ratio (20d)1.12x